Prednisolone and Pentoxifylline Combination in Patients with Severe Acute Alcoholic Hepatitis
نویسندگان
چکیده
Clinical manifestation of alcoholic hepatitis is a serious and adverse sign of progression of alcoholic liver disease. Therapy of acute alcoholic hepatitis is currently limited to symptomatic therapy and prednisolone. The aim of our study was to analyze pentoxifylline and prednisolone combination in patients with severe acute alcoholic hepatitis. 136 patients with severe acute alcoholic hepatitis (Maddrey discriminant function > 32) were included. Patients in the control group (73 patients) received symptomatic therapy, the patients in the first study group (41 patients) additionally received 400-600 mg pentoxifylline intravenously. The second study group (22 patients) additionally treated by combination of pentoxifylline and prednisolone. In the group of patients treated with pentoxifylline significant reduction in creatinine was determined (p <0.05). Short-term mortality in pentoxifylline group of was lower (15 %) than in the control group (25%). In prednisolone and pentoxifylline combination groups was the maximum mortality rate 45%. Pentoxifylline improves short-term survival in patients with severe acute alcoholic hepatitis, significantly reduces the incidence and mortality from hepatorenal syndrome. The combined use of prednisolone and pentoxifylline probably negates the positive effect of pentoxifylline against hepatorenal syndrome.
منابع مشابه
Pentoxifylline Plus Prednisolone versus Pentoxifylline Only for Severe Alcoholic Hepatitis: A Randomized Controlled Clinical Trial
BACKGROUND Prednisolone and pentoxifylline (PTX) have been shown to be individually useful in severe alcoholic hepatitis with Maddrey discriminant function (MDF) score ≥32. Previous report suggests that PTX is probably superior to prednisolone alone. However the efficacy of PTX and prednisolone combination over PTX alone in the management of acute alcoholic hepatitis (MDF score ≥32) is yet unre...
متن کاملTreatment of severe alcoholic hepatitis with corticosteroids and pentoxifylline.
Despite being themost frequently abused drug for centuries, alcohol was not recognized as a direct hepatotoxin until the 1960s.1 Alcohol abuse accounts for the third leading preventable causeofdeath and the secondmost commoncauseof cirrhosis after hepatitis C virus infection in the United States.2,3 Alcoholichepatitis is a commoncomplicationofalcohol abuse; its severity can range frommild to se...
متن کاملPrednisolone with vs without pentoxifylline and survival of patients with severe alcoholic hepatitis: a randomized clinical trial.
IMPORTANCE Prednisolone or pentoxifylline is recommended for severe alcoholic hepatitis, a life-threatening disease. The benefit of their combination is unknown. OBJECTIVE To determine whether the addition of pentoxifylline to prednisolone is more effective than prednisolone alone. DESIGN, SETTING, AND PARTICIPANTS Multicenter, randomized, double-blind clinical trial conducted between Decem...
متن کاملPrednisolone or pentoxifylline for alcoholic hepatitis.
BACKGROUND Alcoholic hepatitis is a clinical syndrome characterized by jaundice and liver impairment that occurs in patients with a history of heavy and prolonged alcohol use. The short-term mortality among patients with severe disease exceeds 30%. Prednisolone and pentoxifylline are both recommended for the treatment of severe alcoholic hepatitis, but uncertainty about their benefit persists. ...
متن کاملAlcoholic hepatitis: Prognosis and treatment.
Alcoholic hepatitis (AH) is a type of acute-on-chronic liver failure and is the most severe form of alcoholic liver disease. AH occurs in patients with heavy alcohol abuse and underlying liver disease. In its severe form, AH carries a poor short-term prognosis. Although the existence of AH can be strongly suspected based on clinical and biochemical criteria, a definitive diagnosis requires a li...
متن کامل